Core Viewpoint - The article highlights the impressive performance of the Huashang Quality Selected Mixed Fund, managed by Dr. Deng Mo, showcasing its ability to outperform benchmarks and indicating a strong investment strategy focused on small-cap growth opportunities [1][4]. Performance Summary - As of May 31, 2025, the A-class share of the fund achieved a net value growth rate of 28.43%, significantly surpassing the performance benchmark of 9.06% and the CSI 300 index at 7.27% [1][6]. - The fund ranks in the top 10% among 1,801 similar products, specifically at 114th place [1]. Management Strategy - Dr. Deng Mo employs a quantitative model to identify high-quality assets in high-growth industries, adapting stock selection logic to different market conditions [1][3]. - The fund maintains an overweight position in small-cap growth stocks, focusing on low-valuation, high-growth companies to balance returns and drawdowns [3][4]. Market Outlook - The article anticipates a market stabilization that will lead to a resurgence of funds into previously corrected growth stocks, particularly small-cap stocks [4]. - The investment strategy will continue to focus on low-valuation, high-growth stocks, with increased allocations in sectors such as machinery, pharmaceuticals, and computers [4]. Long-term Investment Value - The fund's strategy is aligned with long-term investment trends, leveraging policy guidance, technological innovation, and industry upgrades to identify sustainable growth opportunities [3][4]. - The small-cap growth sector is viewed as a representative area of new productive forces, offering extensive investment opportunities across the entire industry chain from basic computing power to end-user applications [4].

Core Insights - The Huashang Quality Selected Mixed Fund, managed by Dr. Deng Mo, has achieved a remarkable one-year net value growth rate of 28.43% as of May 31, 2025, significantly outperforming the benchmark return of 9.06% and the CSI 300 index return of 7.27% [1][3] - The fund ranks in the top 10% among 1,801 similar products in terms of performance [1] Fund Management and Strategy - Dr. Deng Mo, with nearly 14 years of experience in the securities industry, leads the fund and utilizes quantitative models to identify high-quality assets in high-growth industries [1][5] - The fund has maintained an overweight position in small-cap growth stocks since the first quarter, focusing on low-valuation, high-growth companies to balance returns and drawdowns [5] - The investment strategy incorporates long-term value assessment, policy direction, technological innovation trends, and industry upgrades, optimizing sector allocation and factor exposure [5] Market Outlook - The market has shown significant differentiation between large and small-cap stocks, creating opportunities for buying mispriced assets [6] - The fund is expected to continue focusing on low-valuation growth stocks, particularly in the machinery, pharmaceuticals, and computer sectors [6] - The ongoing advancements in AI technology are anticipated to create extensive market opportunities, with small-cap growth stocks representing a key area for long-term investment [6]